Certara, Inc. (NASDAQ:CERT) Receives Average Recommendation of “Hold” from Analysts

Certara, Inc. (NASDAQ:CERT) has been assigned an average rating of “Hold” from the eight ratings firms that are covering the company, Marketbeat reports. Five analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average 1 year target price among brokers that have issued ratings on the stock in the last year is $20.86.

A number of brokerages recently weighed in on CERT. Jefferies Financial Group cut Certara from a “buy” rating to a “hold” rating and decreased their price objective for the company from $24.50 to $17.00 in a report on Tuesday, August 22nd. Credit Suisse Group decreased their price objective on Certara from $27.00 to $21.00 and set an “outperform” rating on the stock in a report on Thursday, August 10th. TheStreet lowered Certara from a “c-” rating to a “d+” rating in a research report on Friday, June 16th. Bank of America reduced their price target on Certara from $27.00 to $24.00 and set a “buy” rating on the stock in a research report on Tuesday, August 15th. Finally, Barclays reduced their price target on Certara from $18.00 to $16.00 and set an “equal weight” rating on the stock in a research report on Friday, August 11th.

Insider Buying and Selling at Certara

In other Certara news, insider Leif E. Pedersen sold 51,224 shares of Certara stock in a transaction on Monday, September 11th. The stock was sold at an average price of $14.60, for a total transaction of $747,870.40. Following the completion of the transaction, the insider now owns 128,883 shares in the company, valued at $1,881,691.80. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 2.60% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently modified their holdings of the business. Wells Fargo & Company MN lifted its holdings in Certara by 12.4% in the fourth quarter. Wells Fargo & Company MN now owns 5,325 shares of the company’s stock valued at $86,000 after acquiring an additional 586 shares during the period. Treasurer of the State of North Carolina increased its position in Certara by 1.3% in the fourth quarter. Treasurer of the State of North Carolina now owns 50,444 shares of the company’s stock worth $811,000 after buying an additional 640 shares in the last quarter. US Bancorp DE increased its position in Certara by 2.8% in the first quarter. US Bancorp DE now owns 23,827 shares of the company’s stock worth $574,000 after buying an additional 640 shares in the last quarter. Commerce Bank increased its position in Certara by 2.2% in the first quarter. Commerce Bank now owns 31,260 shares of the company’s stock worth $754,000 after buying an additional 673 shares in the last quarter. Finally, HighTower Advisors LLC increased its position in Certara by 4.0% in the first quarter. HighTower Advisors LLC now owns 18,537 shares of the company’s stock worth $459,000 after buying an additional 709 shares in the last quarter. 67.26% of the stock is owned by institutional investors.

Certara Stock Down 1.3 %

Shares of NASDAQ CERT opened at $14.37 on Wednesday. Certara has a 52 week low of $10.60 and a 52 week high of $24.96. The business has a 50-day simple moving average of $17.52 and a two-hundred day simple moving average of $19.93. The company has a quick ratio of 3.43, a current ratio of 3.43 and a debt-to-equity ratio of 0.26. The company has a market cap of $2.30 billion, a P/E ratio of 119.75, a P/E/G ratio of 1.03 and a beta of 1.46.

Certara (NASDAQ:CERT) last released its quarterly earnings results on Wednesday, August 9th. The company reported $0.10 earnings per share for the quarter, beating the consensus estimate of $0.08 by $0.02. Certara had a return on equity of 5.56% and a net margin of 5.45%. The firm had revenue of $90.45 million for the quarter, compared to analysts’ expectations of $92.04 million. Research analysts anticipate that Certara will post 0.34 earnings per share for the current fiscal year.

Certara Company Profile

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development.